Friday, 09 May 2025
With Intelligence and the 糖心原创 have agreed an exclusive partnership for The Centre for Private Equity and MBO Research (CMBOR), to expand access to private equity deal data.
CMBOR – part of Nottingham University Business School (NUBS) – was founded in 1986 and maintains a unique database of 48,000 private equity-backed buyout investments across Europe. CMBOR has an unrivalled reputation, collecting and aggregating quantitative deal data across value, volume, region, industry, structure, and exit.
With Intelligence, the leading provider of investment intelligence, continues to invest in developing its private markets offering, providing transparency for investors on the full lifecycle of capital allocation from LP to GP to fund to investment. The partnership aligns with recent acquisitions SPS (Sutton Place Strategies), and The Deal, providing best in class deal news, data and proprietary pipeline tracking and deal origination capabilities.
The strategic agreement allows With Intelligence the ability to integrate CMBOR data into existing products, enhancing the breadth and depth of private equity coverage.
Collecting data and providing market intelligence has evolved tremendously since CMBOR's inception. We are very excited to have With Intelligence as a partner, who will take CMBOR's data and reach to the next level.鈥�
For over 38 years, the CMBOR database has been used to produce quarterly reports for industry professionals, academics and regulators. The Centre’s market intelligence on private equity activity and analyses of trends provide independent analysis and advice, to enhance government and industry understanding of the private equity market and inform the development of policy and practice.
Cornelia Andersson, Chief Product Officer at With Intelligence, said “This is a very exciting agreement for us. By integrating CMBOR with our existing private equity data we’ll bring further value to our customers looking for opportunities within private markets, and improve transparency for investors and capital allocators.”
Story credits
More information is available from Professor Kevin Amess, Director of CMBOR, via kevin.amess@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.